
Patents, Exclusivity, And The Generic Clock
A new medicine does not simply face competition the day after approval. Patents and FDA exclusivity periods decide when generic makers may step in, and that clock explains much of what you see in the approvals feed on this site. A brand new active ingredient typically enjoys years of market protection, then a parade of abbreviated applications follows, visible in the approvals list as new dosage forms and makers multiply. The Orange Book, covered in the generics guide, tracks therapeutic equivalence with AB codes.
Watch the approvals search for a drug you know, and count how many manufacturers appear once protection lapses..
Back to Blog